Skip to content

GHK-Cu

Human clinical Skin & Hair In 3 protocols 3 sources

GHK-Cu is a naturally occurring copper complex first isolated from human plasma. Research shows it plays a significant role in promoting wound healing, stimulating collagen synthesis, and modulating gene expression to support tissue repair and anti-aging processes.

01Dosing reference

Amount
1-2 mg/day (SubQ) or 1-3% concentration (topical)
Frequency
Once daily
Cycle
4-8 weeks on, 2-4 weeks off
Reference figures, not a recommendationThese values reflect amounts described in the literature and vendor documentation this database indexes. Use the reconstitution calculator to convert them into syringe units.

02Mechanism of action

01

Copper binding and transport

GHK strongly binds to copper(II) ions, facilitating their transport into cells where copper is essential for various enzymatic processes.

02

Gene expression modulation

It upregulates genes associated with collagen and elastin production while downregulating genes involved in inflammation and tissue destruction.

03

Tissue repair and regeneration

This leads to accelerated wound healing, improved skin elasticity, and potential systemic anti-aging effects.

03Human evidence

Improved skin appearance and reduced wrinkles

Multiple clinical trials using topical GHK-Cu creams showed significant improvements in skin elasticity, clarity, and reduction of fine lines compared to placebo.

Enhanced wound healing

Clinical studies on patients with diabetic ulcers and other chronic wounds demonstrated accelerated closure rates when treated with GHK-Cu formulations.

04Preclinical evidence

Stimulation of blood vessel growth (angiogenesis)

Animal models of ischemia showed that GHK-Cu increased the formation of new blood vessels, improving blood flow to damaged tissues.

Anti-inflammatory and antioxidant effects

In vitro studies demonstrated that GHK-Cu reduces the production of inflammatory cytokines and protects cells from oxidative stress.

05What is known vs. unknown

Reasonably established
  • Stimulates the production of collagen and elastin, improving skin structure.
  • Possesses strong anti-inflammatory and antioxidant properties.
  • Promotes wound healing and tissue regeneration.
  • Modulates the expression of numerous genes related to cellular health and aging.
Unknowns & limits
  • The optimal systemic dosing and long-term safety of injectable GHK-Cu in humans remain under-researched.
  • Bioavailability and stability of different formulations (topical vs. injectable) can vary significantly.

06Safety & regulatory context

Regulatory statusGHK-Cu is widely used in cosmetic products and is generally considered safe for topical use with minimal side effects. Injectable forms are used in research and off-label anti-aging protocols, but they are not FDA-approved for systemic use. Potential side effects of systemic use include injection site reactions and, theoretically, copper toxicity if used excessively, though this is rare at typical research doses.

07Compared with BPC-157

GHK-Cu vs. BPC-157
Key difference
While both promote healing, GHK-Cu specifically acts through copper transport and gene modulation with a strong focus on skin and systemic anti-aging, whereas BPC-157 primarily targets gut health, tendon, and muscle repair via angiogenesis and nitric oxide pathways.
When researchers discuss each
GHK-Cu is often discussed in the context of cosmetic dermatology, skin aging, and systemic rejuvenation, while BPC-157 is favored for acute musculoskeletal injuries and gastrointestinal healing.

08Appears in protocols

09Glossary

Angiogenesis
The physiological process through which new blood vessels form from pre-existing vessels.
Glycosaminoglycans
Long unbranched polysaccharides that are a primary component of connective tissue, helping to maintain hydration and structural integrity.
Fibroblasts
Cells in connective tissue that produce collagen and other fibers.

10Knowledge check

Q1What is the primary mechanism by which GHK-Cu promotes tissue repair?
Q2Which of the following is a well-documented benefit of topical GHK-Cu in human trials?
Q3Which statement best reflects a documented limitation of the current human evidence for systemic (injectable) GHK-Cu in the dossier?
Q4According to the dossier, in which research context is GHK-Cu most likely discussed compared with BPC-157?
Q5Which statement most accurately reflects the dossier’s safety and regulatory context for GHK-Cu?

11Sources

More in Skin & Hair

See all
Research and educational use onlyNothing on this site is medical advice, a prescription, or a recommendation for human use. Compounds documented here are research chemicals. Consult a qualified clinician before making any health decision.